Impact of a VI-polysaccharide conjugate vaccine in preventing Typhoid Fever in an endemic setting, Lalitpur, Nepal

Impact of a VI-polysaccharide conjugate vaccine in preventing Typhoid Fever in an endemic setting, Lalitpur, Nepal

<p>Globally, an estimated 11 to 21 million cases of febrile illness and 117,000 to 161,000 deaths are attributed to typhoid fever each year. Typhoid fever is prevalent mainly in low-resource settings with poor water, and inadequate sanitation and hygiene facilities, with South Asia accounting...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoir:	Shakya, M
Rannpháirtithe:	Pollard, A
Formáid:	Tráchtas
Teanga:	English
Foilsithe / Cruthaithe:	2022
Ábhair:	Typhoid fever Typhoid vaccine Typhoid Conjugate Vaccine Vaccine Efficacy

Míreanna comhchosúla

Cost-effectiveness analysis of typhoid conjugate vaccines in an outbreak setting: a modeling study
de réir: Maile T. Phillips, et al.
Foilsithe / Cruthaithe: (2023-03-01)

Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: A randomized controlled phase 2 trial
de réir: Sodiomon B. Sirima, et al.
Foilsithe / Cruthaithe: (2021-07-01)

Costs of typhoid vaccination for international travelers from the United States
de réir: Heesoo Joo, et al.
Foilsithe / Cruthaithe: (2025-03-01)

Single and two-dose typhoid conjugate vaccine safety and immunogenicity in HIV-exposed uninfected and HIV-unexposed uninfected Malawian children
de réir: Nginache Nampota-Nkomba, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000 Salmonella Typhi genomes
de réir: Megan E Carey, et al.
Foilsithe / Cruthaithe: (2023-09-01)

A phase II clinical trial of a Vi-DT typhoid conjugate vaccine in healthy Indonesian adolescents and adults: one-month evaluation of safety and immunogenicity
de réir: Sukamto Koesnoe, et al.
Foilsithe / Cruthaithe: (2024-02-01)

Public engagement during a typhoid conjugate vaccine trial in Lalitpur, Nepal- experience, challenges and lessons learnt
de réir: Ashata Dahal, et al.
Foilsithe / Cruthaithe: (2022-11-01)

A Study on Longevity of Immune Response after Vaccination with Salmonella Typhi Vi Conjugate Vaccine (Pedatyph™) in Children
de réir: Balaji Chinnasami, et al.
Foilsithe / Cruthaithe: (2015-05-01)

Evaluation of Typhoid Conjugate Vaccine Effectiveness in Ghana (TyVEGHA) Using a Cluster-Randomized Controlled Phase IV Trial: Trial Design and Population Baseline Characteristics
de réir: Andrea Haekyung Haselbeck, et al.
Foilsithe / Cruthaithe: (2021-03-01)

Assessment of vaccine herd protection in a cluster-randomised trial of Vi conjugate vaccine against typhoid fever: results of further analysisResearch in context
de réir: Farhana Khanam, et al.
Foilsithe / Cruthaithe: (2023-04-01)

Implementation of an outbreak response vaccination campaign with typhoid conjugate vaccine – Harare, Zimbabwe, 2019
de réir: M. Poncin, et al.
Foilsithe / Cruthaithe: (2022-12-01)

An observer-blinded, cluster randomised trial of a typhoid conjugate vaccine in an urban South Indian cohort
de réir: Nikhil Sahai, et al.
Foilsithe / Cruthaithe: (2023-08-01)

A forecast of typhoid conjugate vaccine introduction and demand in typhoid endemic low- and middle-income countries to support vaccine introduction policy and decisions
de réir: Vittal Mogasale, et al.
Foilsithe / Cruthaithe: (2017-09-01)

Typhoid vaccines. Historical aspects of typhoid vaccine development, and currently available products
de réir: M. V. Abramtseva, et al.
Foilsithe / Cruthaithe: (2021-07-01)

Immunogenicity and reactogenicity of a booster dose of a typhoid conjugate vaccine (TCV) in Malawian pre-school childrenResearch in context
de réir: Nginache Nampota-Nkomba, et al.
Foilsithe / Cruthaithe: (2025-03-01)

Atypical Presentation of Typhoid Fever
de réir: Deepak Madi
Foilsithe / Cruthaithe: (2013-12-01)

Safety and immunogenicity of Vi-diphtheria toxoid typhoid conjugate vaccine among children below 2 years: a systematic review and meta-analysis
de réir: Amira Mohamed Taha, et al.
Foilsithe / Cruthaithe: (2024-04-01)

Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: Phase II, randomized, dose-scheduling, observer-blind Study
de réir: Maria Rosario Capeding, et al.
Foilsithe / Cruthaithe: (2020-10-01)

Emergence of Multidrug-Resistant (MDR) and Extensively Drug- Resistant (XDR) Typhoid Fever in Aligarh, Uttar Pradesh: A Case Series
de réir: Mohd Arif, et al.
Foilsithe / Cruthaithe: (2023-06-01)

Emergence of Multidrug-Resistant (MDR) and Extensively Drug- Resistant (XDR) Typhoid Fever in Aligarh, Uttar Pradesh: A Case Series
de réir: Mohd Arif, et al.
Foilsithe / Cruthaithe: (2023-06-01)

Strategies to Improve Coverage of Typhoid Conjugate Vaccine (TCV) Immunization Campaign in Karachi, Pakistan
de réir: Farah Naz Qamar, et al.
Foilsithe / Cruthaithe: (2020-11-01)

Barriers to typhoid fever vaccine access in endemic countries
de réir: Khan MI, et al.
Foilsithe / Cruthaithe: (2017-03-01)

IAPSM’s Position Paper on Typhoid Vaccines for Adult Immunization in India
de réir: Kapil Goel, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China
de réir: Yang H.H., et al.
Foilsithe / Cruthaithe: (2001-01-01)

Longevity of immune response after a single dose of typhoid conjugate vaccine against Salmonella Typhi among children in Hyderabad, Pakistan
de réir: Farah Naz Qamar, et al.
Foilsithe / Cruthaithe: (2024-10-01)

Why Is Eradicating Typhoid Fever So Challenging: Implications for Vaccine and Therapeutic Design
de réir: Yi-An Yang, et al.
Foilsithe / Cruthaithe: (2018-07-01)

The unrecognized burden of typhoid fever
de réir: Stephen K. Obaro, et al.
Foilsithe / Cruthaithe: (2017-03-01)

Anti-S. typhi Vi IgG levels in children with and without typhoid vaccinations
de réir: Sriandayani Sriandayani, et al.
Foilsithe / Cruthaithe: (2014-10-01)

Bilateral retinitis following typhoid fever
de réir: M. Prabhushanker, et al.
Foilsithe / Cruthaithe: (2017-04-01)

Kinetics of natural and acquired immunity to typhoid fever
de réir: Pulickal, A, et al.
Foilsithe / Cruthaithe: (2008)

A description of a pre-emptive typhoid Vi capsular polysaccharide vaccination campaign after the 2015 earthquake in Nepal and vaccine effectiveness evaluation
de réir: Bhim Gopal Dhoubhadel, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses
de réir: Siân E. Jossi, et al.
Foilsithe / Cruthaithe: (2023-03-01)

A multi-centre, post-marketing surveillance study of Vi polysaccharide–tetanus toxoid conjugate vaccine (Typbar TCV®) in India
de réir: Raghu Reddy, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Induction of Cell Cycle and NK Cell Responses by Live-Attenuated Oral Vaccines against Typhoid Fever
de réir: Christoph J. Blohmke, et al.
Foilsithe / Cruthaithe: (2017-10-01)

Salmonella enterica Serovar Typhi on an Island: No H58, No Multidrug Resistance, but for How Long?
de réir: Arif Mohammad Tanmoy
Foilsithe / Cruthaithe: (2022-12-01)

Cost-effectiveness analysis of typhoid vaccination in Lao PDR
de réir: Mick Soukavong, et al.
Foilsithe / Cruthaithe: (2023-11-01)

Typhoid vaccine: A case for inclusion in national program
de réir: Pragya Sharma, et al.
Foilsithe / Cruthaithe: (2011-01-01)

A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2–11 years: a phase II preliminary report
de réir: Bernie Endyarni Medise, et al.
Foilsithe / Cruthaithe: (2020-10-01)

Jejunal multiple perforations for combined abdominal typhoid fever and miliary peritoneal tuberculosis
de réir: Michele Grieco, et al.
Foilsithe / Cruthaithe: (2019-05-01)

Typhoid Fever: an Epidemiologic Survey of Suspected Cases Referred to Diagnostic Laboratories in Rasht, 2002 -3
de réir: A Amirkhani, et al.
Foilsithe / Cruthaithe: (2006-03-01)